ID Week 2018: sterren, superbugs en late breakers

Bronnen:

1. Garg S. Age-related differences in influenza type/subtype among patients hospitalized with influenza, FluSurv-NET—2017–2018. ID Week 2018, abstract LB17.,Chang L-J. Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older. ID Week 2018, abstract LB14.,Ison MG. Phase 3 Trial of Baloxavir Marboxil in High Risk Influenza Patients (CAPSTONE-2 Study). ID Week 2018, abstract LB16.,Wolf J. Safety and Efficacy of Fidaxomicin and Vancomycin in Pediatric Patients with Clostridium difficile Infection: Phase III, Multicenter, Investigator-blind, Randomized, Parallel Group (SUNSHINE) Study. ID Week 2018, abstract LB12.,Pujol M. LB3. Daptomycin plus Fosfomycin versus Daptomycin Monotherapy for Methicillin-resistant Staphylococcus aureus Bacteremia. A Multicenter, Randomized, Clinical Trial. ID Week 2018, abstract LB3.